Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 24. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_935Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_936Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_937Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_938Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 virus particle/ cell90% cancer cell survive after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_967Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 virus particle/cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_968Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_969Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_970Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1023Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1024Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1025Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1026Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 pfu/cell70% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1027Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1028Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 pfu/cell80% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1029Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 pfu/cell75% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1030Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 pfu/cell10% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1031Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 pfu/cell80% cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1032Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 pfu/cell50% cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1033Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 pfu/cell30% cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1034Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 pfu/cell100% cell killing after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1035Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 pfu/cell50% cell survival after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1036Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 pfu/cell100% cell killing after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1037Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 pfu/cell100% cell killing after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1038Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 pfu/cell100% cell killing after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577